ProQR Therapeutics N.V. (PRQR) stock
PRQRNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.15−0.03 (-2.54%)
Close on Nov 17, 2026Market cap $121.17MP/E –Yield –
ProQR Therapeutics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
ProQR Therapeutics's price to sales ratio was 6.6× on Nov 11, 2026, against 13.5× a year earlier. Over the last 5 years it ranged from 5.6× to 79.3×, with a median of 16.6×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 6.6× | −5.0 |
| 2025 | Dec 31, 2025 | 11.5× | −0.2 |
| 2024 | Dec 31, 2024 | 11.7× | −24.0 |
| 2023 | Dec 29, 2023 | 35.7× | −43.5 |
| 2022 | Dec 30, 2022 | 79.3× | – |
See a number that looks wrong?